Art Daily: FotoFocus grants $800,000 to Ohio and Kentucky's art communities
FotoFocus, the non-profit arts organization behind America’s largest photography biennial, announced that in lieu of presenting its fifth FotoFocus Biennial, originally slated for October 2020, it will pledge its budget to financially support regional art communities during the COVID-19 pandemic, including the University of Cincinnati.
The organization will grant $800,000 to more than 100 participating venues and partners that were selected to present as part of the 2020 FotoFocus Biennial. As part of this pledge, FotoFocus will support UC's College of Design, Architecture, Art, and Planning and 14 other academic institutions with grants totaling more than $177,000.
DAAP Galleries have been FotoFocus venues and many UC faculty, students and alumni have been involved in the biennial event. Read more.
Featured image at top: 'No Two Alike' exhibition with Thomas Ruff, part of FotoFocus Biennial 2018. Photo/Jacob Drabik
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.